Alignment Healthcare, Inc. reported significant financial growth in its latest quarterly filing, with total revenues reaching $1.235 billion for the three months ended March 31, 2026, a 33.3% increase from $926.9 million in the same period last year. The growth was primarily driven by a 30.9% increase in health plan membership, which rose to 284,800 members. The company also achieved a net income of $11.4 million, a substantial turnaround from a net loss of $9.4 million in the prior year, marking a 222% improvement.
The company's medical expenses also increased, totaling $1.091 billion, up 32.9% from $820.9 million in the previous year. This rise in expenses was attributed to the growing membership base and higher benefits for members in certain plans. Selling, general, and administrative expenses rose by 16.7% to $121.1 million, reflecting ongoing investments in operations, technology, and marketing to support membership growth. Despite these increases, the medical benefits ratio slightly improved to 88.2% from 88.4%, indicating effective management of medical costs relative to revenues.
In terms of strategic developments, Alignment Healthcare has expanded its market presence, now offering Medicare Advantage plans in 45 markets across five states, including California and North Carolina. The company has also discontinued its participation in the ACO Reach program, which had a minimal impact on its financial results. The firm continues to invest in its proprietary technology platform, AVA, which integrates data insights with clinical care to enhance member experiences and outcomes.
Operationally, Alignment Healthcare reported a significant increase in cash flow, with net cash provided by operating activities rising to $128.7 million, compared to $16.6 million in the prior year. The company ended the quarter with $707.7 million in cash and cash equivalents, reflecting a strong liquidity position. The firm’s long-term debt remained stable at approximately $323.6 million, with no outstanding debt under its new $200 million revolving credit facility established in February 2026.
Looking ahead, Alignment Healthcare aims to capitalize on its growth opportunities by expanding into new markets and enhancing its service offerings. The company anticipates continued investments in technology and operations to support its growth strategy, while also navigating the challenges of a competitive healthcare landscape. The management remains optimistic about achieving long-term profitability and enhancing shareholder value through its consumer-centric healthcare model.
About Alignment Healthcare, Inc.
Alignment Healthcare, Inc. operates as a Medicare Advantage health plan focused on serving seniors in the United States. It offers integrated, data-driven healthcare solutions through proprietary technology and an in-house clinical model to improve outcomes and reduce costs. The company contracts directly with CMS, providing coordinated care via its AVA platform and Care Anywhere program, emphasizing personalized, proactive management of chronic conditions and a premium member experience.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.